First drug to treat wintertime blues approved

updated 3:32 p.m. ET June 12, 2006

WASHINGTON - An antidepressant won federal approval Monday as the first drug to treat seasonal affective disorder, the wintertime blues that can strike when the days grow short.

Wellbutrin XL can be used in the prevention of major depressive episodes in patients with a history of seasonal affective disorder, often called SAD, the Food and Drug Administration said.

SAD is characterized by recurrent major depressive episodes during the fall and winter.

The FDA approved Wellbutrin XL — the extended release version of bupropion HCL in tablet form — in 2003. The original version of the drug won approval in 1985.

Wellbutrin XL is manufactured by GlaxoSmithKline.

MORE FROM MENTAL HEALTH

Mental health Section Front

Marriage wards off blues, just don't end it Climate change fears may worsen depression Six tips to help you feel instantly calm Autism seen as asset, not liability, in some jobs Coroner: Self-help course led to suicide Teen Internet addicts more likely to self harm Dark shadows loom over ‘facilitated’ talk Compulsive hoarders suddenly in the spotlight Early treatment may help kids with autism Military experiment seeks to predict PTSD Mental health Section Front   Add Mental health headlines to your news reader: